An Empirical Biomarker-Based Calculator for Cystic Index in a Model of Autosomal Recessive Polycystic Kidney Disease-The Nieto-Narayan Formula.
Autosomal recessive polycystic kidney disease (ARPKD) is associated with progressive enlargement of the kidneys fuelled by the formation and expansion of fluid-filled cysts. The disease is congenital and children that do not succumb to it during the neonatal period will, by age 10 years, more often than not, require nephrectomy+renal replacement therapy for management of both pain and renal insufficiency. Since increasing cystic index (CI; percent of kidney occupied by cysts) drives both renal expansion and organ dysfunction, management of these patients, including decisions such as elective nephrectomy and prioritization on the transplant waitlist, could clearly benefit from serial determination of CI. So also, clinical trials in ARPKD evaluating the efficacy of novel drug candidates could benefit from serial determination of CI. Although ultrasound is currently the imaging modality of choice for diagnosis of ARPKD, its utilization for assessing disease progression is highly limited. Magnetic resonance imaging or computed tomography, although more reliable for determination of CI, are expensive, time-consuming and somewhat impractical in the pediatric population. Using a well-established mammalian model of ARPKD, we undertook a big data-like analysis of minimally- or non-invasive blood and urine biomarkers of renal injury/dysfunction to derive a family of equations for estimating CI. We then applied a signal averaging protocol to distill these equations to a single empirical formula for calculation of CI. Such a formula will eventually find use in identifying and monitoring patients at high risk for progressing to end-stage renal disease and aid in the conduct of clinical trials.
Department of Preclinical Research, Angion Biomedica Corp., Uniondale, New York, United States of America.
Jake A
http://orcid.org/0000-0002-7007-0245
JA
Nieto
Department of Preclinical Research, Angion Biomedica Corp., Uniondale, New York, United States of America.
Michael A
MA
Yamin
Department of Preclinical Research, Angion Biomedica Corp., Uniondale, New York, United States of America.
Itzhak D
ID
Goldberg
Department of Preclinical Research, Angion Biomedica Corp., Uniondale, New York, United States of America.
Prakash
http://orcid.org/0000-0002-7007-0245
P
Narayan
D000818:Animals; D015415:Biomarkers / Q000097:blood / Q000652:urine; D001806:Blood Urea Nitrogen; D002648:Child; D003404:Creatinine / Q000097:blood; D055316:Cystatin C / Q000097:blood; D003560:Cysts / Q000473:pathology; D000072596:Hepatitis A Virus Cellular Receptor 1 / Q000097:blood; D006801:Humans; D020382:Interleukin-18 / Q000097:blood; D007668:Kidney / Q000000981:diagnostic imaging / Q000378:metabolism / Q000503:physiopathology; D016030:Kidney Transplantation; D000071068:Lipocalin-2 / Q000097:blood; D008279:Magnetic Resonance Imaging; D051379:Mice; D017044:Polycystic Kidney, Autosomal Recessive / Q000097:blood* / Q000000981:diagnostic imaging / Q000473:pathology / Q000652:urine*; D051381:Rats; D051437:Renal Insufficiency / Q000097:blood* / Q000473:pathology / Q000652:urine*; D012720:Severity of Illness Index; D014463:Ultrasonography
D015415:Biomarkers; D055316:Cystatin C; C491143:HAVCR1 protein, human; D000072596:Hepatitis A Virus Cellular Receptor 1; D020382:Interleukin-18; D000071068:Lipocalin-2; D003404:Creatinine
Pediatr Transplant. 2014 Nov;18(7):726-32
25074681
Pediatrics. 2003 May;111(5 Pt 1):1072-80
12728091
PLoS One. 2015 Apr 13;10(4):e0123555
25875363
Kidney Int. 2001 Jan;59(1):126-36
11135065
PLoS One. 2013;8(1):e53016
23326375
Semin Nephrol. 2011 May;31(3):237-44
21784272
Pediatrics. 2014 Sep;134(3):e833-45
25113295
Clin J Am Soc Nephrol. 2011 Oct;6(10):2499-507
21903984
Clin J Am Soc Nephrol. 2010 Jun;5(6):972-84
20413436